Mountain Crest Acquisition Corp. V (MCAG): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$742.0K

Year ended 2025-12-31

-$664.3K

Trailing 12 months to 2026-06-30

2022-12-31 Operating Cash Flow (USD) 2025-12-31

Period ended	Operating Cash Flow	Change YoY	Source filing
2025-12-31	-$742.0K	n/m	2026-03-16, From 2025-01-01
2024-12-31	-$921.2K	n/m	2026-03-16, From 2024-01-01
2023-12-31	-$470.7K	n/m	2025-04-01, From 2023-01-01
2022-12-31	-$446.4K	n/a	2024-08-26, From 2022-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Cash Flow	Change YoY
Mountain Crest Acquisition Corp. V (MCAG)	2025-12-31	-$742.0K	n/m
Vycor Medical Inc (VYCO)	2025-12-31	-$13.5K	n/m
Family Office of America, Inc. (FOFA)	2025-12-31	-$262.2K	n/m
Nuo Therapeutics, Inc. (AURX)	2025-12-31	-$865.0K	n/m
Vivos Inc (RDGL)	2025-12-31	-$2.06M	n/m
QHSLab, Inc. (USAQ)	2025-12-31	$178.1K	+25.1%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)	2025-12-31	-$3.83M	n/m
Sigyn Therapeutics, Inc. (SIGY)	2024-12-31	-$872.4K	n/m
PetVivo Holdings, Inc. (PETV)	2026-03-31	-$6.11M	n/m

Compare MCAG, VYCO, FOFA, AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗